November 1, 2025/
Eco-Pharmacovigilance (Eco-PV) is a critical and emerging field that extends the principles of pharmacovigilance from human safety to environmental safety. In simple terms, while traditional PV asks, "Is this...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Eco-Pharmacovigilance (Eco-PV) is a critical and emerging field that extends the principles of pharmacovigilance from human safety to environmental safety. In simple terms, while traditional PV asks, "Is this...
This document is an official guideline from the EMA, finalized in October 2015. Its primary purpose is to provide standardized, clear instructions for all stakeholders in...
This WHO document is a practical guide and handbook specifically focused on the pharmacovigilance of medicines used to treat tuberculosis (TB).
